Interferon and interferon-induced cytokines as markers of impending clinical progression in ANA+ individuals without a systemic autoimmune rheumatic disease diagnosis

Interferon and interferon-induced cytokines as markers of impending clinical progression in ANA+ individuals without a systemic autoimmune rheumatic disease diagnosis

Abstract Background Elevated levels of interferons (IFNs) are a characteristic feature of systemic autoimmune rheumatic diseases (SARDs) and may be useful in predicting impending symptomatic progression in anti-nuclear antibody-positive (ANA+) individuals lacking a SARD diagnosis. Typically, these a...

Full description

Bibliographic Details
Main Authors: Sonya T. Kim, Carolina Muñoz-Grajales, Shannon E. Dunn, Raphael Schneider, Sindhu R. Johnson, Zahi Touma, Zareen Ahmad, Dennisse Bonilla, Eshetu G. Atenafu, Linda T. Hiraki, Arthur Bookman, Joan Wither
Format: Article
Language:English
Published: BMC 2023-02-01
Series:Arthritis Research & Therapy
Subjects:
Systemic autoimmune rheumatic diseases
Pre-clinical
Interferon
Cytokines
Online Access:https://doi.org/10.1186/s13075-023-02997-w

Internet

https://doi.org/10.1186/s13075-023-02997-w

Similar Items